Stock 603896 ZHEJIANG SHOUXIANGU PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Equities

603896

CNE100002XJ4

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 24/06/2024 BST 		5-day change 1st Jan Change
22.8 CNY -3.18% Intraday chart for Zhejiang Shouxiangu Pharmaceutical Co., Ltd. -9.31% -29.28%
04-25 Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Business Summary

Zhejiang Shouxiangu Pharmaceutical Co Ltd is a China-based company principally engaged in the breeding, cultivation, processing and sales of traditional Chinese medicinal materials, such as the ganoderma lucidums and dendrobium officinales. The Company's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The Company mainly operates its businesses in domestic markets through wholesaling and direct sales.

Number of employees: 1,143

Sales per Business

CNY in Million2022Weight2023Weight Delta
Broken Ganoderma Lucidum Spore Powder
31.1 %
260 31.4 % 244 31.1 % -6.17%
Broken Ganoderma Lucidum Spore Powder Granules
17.6 %
137 16.5 % 138 17.6 % +0.83%
Ganoderma Lucidum Spore Powder (Broken Wall)
16.3 %
145 17.5 % 128 16.3 % -11.83%
Others
14.0 %
109 13.1 % 110 14.0 % +1.07%
Iron Skin Maple Bucket Granule
11.8 %
91 11.0 % 93 11.8 % +1.54%
Iron-skin Maple Bucket Glossy Ganoderma Extract
4.3 %
38 4.6 % 34 4.3 % -10.60%
Broken Ganoderma Lucidum Spore Powder Tablet
3.0 %
37 4.5 % 24 3.0 % -36.69%
Other Business
1.8 %
11 1.4 % 14 1.8 % +22.89%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
829 100.0 % 784 100.0 % -5.39%

Managers

Managers TitleAgeSince
Zhen Yu Li CEO
 Chief Executive Officer 33 -
Ming Yan Li FOU
 Founder 64 02/03/97
Jing Xu BRD
 Director/Board Member 39 18/04/19
Hang Feng Huang BRD
 Director/Board Member 41 -
Guo Fang Liu BRD
 Director/Board Member 48 01/12/13

Members of the board

Members of the board TitleAgeSince
Ru Wei Wang BRD
 Director/Board Member 57 25/05/21
Ming Yan Li FOU
 Founder 64 02/03/97
Zhen Hao Li BRD
 Director/Board Member 37 24/05/13
Jing Xu CHM
 Chairman 39 -
Ling Juan Hu BRD
 Director/Board Member 37 11/02/17
Guo Fang Liu BRD
 Director/Board Member 48 01/12/13
Zhen Yu Li CEO
 Chief Executive Officer 33 -
Hai Min Han BRD
 Director/Board Member 51 18/04/19
Sai Bei BRD
 Director/Board Member 40 21/04/22
Hang Feng Huang BRD
 Director/Board Member 41 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 201,828,671 114,555,987 ( 56.76 %) 5,240,929 ( 2.597 %) 56.76 %

Shareholders

NameEquities%Valuation
Li Ming Yan Family
28.76 %
56,711,239 28.76 % 211 M ¥
Zhen Hao Li
7.628 %
15,041,650 7.628 % 56 M ¥
Fullgoal Fund Management Co., Ltd.
7.541 %
14,871,276 7.541 % 55 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
3.215 %
6,340,569 3.215 % 24 M ¥
Zhen Yu Li
2.593 %
5,114,161 2.593 % 19 M ¥
Huashang Fund Management Co., Ltd.
2.380 %
4,692,949 2.380 % 17 M ¥
Orient Securities Asset Management Co. Ltd.
2.286 %
4,507,680 2.286 % 17 M ¥
ZHEJIANG SHOUXIANGU PHARMACEUTICAL CO., LTD.
1.818 %
3,585,000 1.818 % 13 M ¥
GF Fund Management Co., Ltd.
1.054 %
2,078,127 1.054 % 8 M ¥
Rongtong Fund Management Co., Ltd.
0.4452 %
878,000 0.4452 % 3 M ¥

Holdings

NameEquities%Valuation
ZHEJIANG SHOUXIANGU PHARMACEUTICAL CO., LTD.
1.82%
 3,585,000 1.82% 13,357,136 $

Company contact information

Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

12 Huanglong 3rd Road Wuyi County

321200, Jinhua

+

http://www.sxg1909.com
address Zhejiang Shouxiangu Pharmaceutical Co., Ltd.(603896)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Ratings for Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
22.8 CNY
Average target price
55.6 CNY
Spread / Average Target
+143.86%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
ZHEJIANG SHOUXIANGU PHARMACEUTICAL CO., LTD. Stock Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
-29.28% 622M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+29.76% 5.69B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-32.34% 3.53B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
-2.23% 3.06B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-25.26% 2.62B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-10.88% 2.29B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+40.09% 1.86B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+40.90% 1.43B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-15.16% 1.41B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK Stock PT Industri Jamu dan Farmasi Sido Muncul Tbk
+42.86% 1.4B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 603896 Stock
  4. Company Zhejiang Shouxiangu Pharmaceutical Co., Ltd.